Contract Pharma Magazine

April 2021

March 2021

January/February 2021

January/February 2021

November/December 2020

November/December 2020

November/December 2020

Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up

Identifying, assessing and mitigating threats at every stage of the development pipeline.
11.17.20
Ensuring Quality During the Transfer and Scale Up of Rx Drugs

Defining the key parameters and considerations for a successful technology transfer.
11.17.20
Inspecting the Unexpected

Preparing quality control processes for COVID-19 vaccine candidates.
11.17.20
Cold Chain Trends

There is a growing need for convenience through Direct-to-Patient and Direct-from-Patient services in clinical trials.
11.17.20
Catering for the Complex

The rapidly changing landscape of pharmaceutical packaging.
11.17.20
Biopharma Contract Manufacturing: Robust Growth Ahead

The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
11.17.20
DCAT President Talks COVID-19, Drug Manufacturing and Innovation

Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
11.17.20
The Single-Use Mixing Landscape: Evaluating Your Options

Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
11.17.20
Self-Medication: Flexibility for Patients and Drug Manufacturers

Bringing together self-medication with auto-injectors and sustainable secondary packaging.
11.17.20
Decentralized Trials Fuel AI Revolution in Clinical Research

The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
11.17.20
Bye-Bye China?

Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
11.17.20

Managing Your Career
The Art and Science of Recruitment

Chapter Three: Landing the Best Candidate.
11.17.20

FDA Watch
The Importance of Hypothesis Testing During Investigations

Why it is critical to have controls in place during out-of-specification investigations to provide quality assurance.
11.17.20

India Report
Injectables Firms Expand Capacity

CDMOs see steriles demand grow.
11.17.20

Back Page
Cell & Gene Therapy Supply Chain: Early Preparation is Key

Supply chain management for cell and gene therapies requires precise demand planning and forecasting.
11.17.20

Columns
A Potential “Marriage”

Initiator companies and generics/CMOs working together.
11.17.20
Columns
When Politics and Science Collide

COVID-19 illustrates why science should always be a principal informer of politics to make better and smarter decisions.
11.17.20